Answers are grounded in this paper and cite their sources.
Background: Psoriasis is a chronic inflammatory skin disease in which the dysfunction of the innate immune cell barrier (IICB) is implicated. However, the underlying molecular mechanisms remain incompletely elucidated. This study aimed to identify and characterize IICB-related biomarkers and their regulatory networks, thereby elucidating their roles in psoriasis pathogenesis. Methods: We obtained psoriasis-related transcriptomic datasets and a list of IICB-related genes (IICB-RGs) from public databases and the literature. We performed differential expression analysis to identify DEGs, then intersected them with IICB-RGs to identify candidate genes. We then used protein-protein interaction (PPI) network analysis, machine learning, and expression validation to identify biomarkers. We constructed a nomogram to evaluate the diagnostic probability of psoriasis. We investigated the biological functions of the biomarkers through enrichment and immune microenvironment analyses. We also predicted the upstream regulatory network and screened potential therapeutic drugs targeting the biomarkers. Results: ARG1 and S100A12 were identified as biomarkers. The diagnostic nomogram incorporating these biomarkers demonstrated excellent predictive performance. Notably, both ARG1 and S100A12 were significantly enriched in key pathways, including "Toll-like receptor signaling pathway", "cytosolic DNA-sensing pathway", and "cell cycle". Immune microenvironment analysis revealed marked dysregulation of immune cells in psoriasis and showed that both biomarkers exhibited highly similar correlation patterns with differentially infiltrated immune cell populations. Moreover, hsa-miR-27a-3p was identified as a common regulator that targets both biomarkers. Drug prediction identified 21 drugs for ARG1 (e.g., Dequalinium) and 5 for S100A12 (e.g., Eptinezumab). Conclusion: This study identified ARG1 and S100A12 as pivotal IICB-related biomarkers in psoriasis, providing insights into their roles in dysregulated immune pathways and the skewed immune microenvironment. The constructed regulatory network and predicted therapeutic agents provide valuable resources for understanding psoriasis pathogenesis and exploring potential treatment strategies.
No takes yet. Share an insight, caveat, or question.
Khalaf et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: